Home
>
National Drug Code (NDC)
>
Tessalon
Tessalon - 0069-0122-02 - (benzonatate)
Drug Information of Tessalon
| Product NDC: | 0069-0122 |
| Proprietary Name: | Tessalon |
| Non Proprietary Name: | benzonatate |
| Active Ingredient(s): | 100 mg/1 & nbsp; benzonatate |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Tessalon
| Product NDC: | 0069-0122 |
| Labeler Name: | Pfizer Laboratories |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA011210 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19580210 |
Package Information of Tessalon
| Package NDC: | 0069-0122-02 |
| Package Description: | 500 CAPSULE in 1 BOTTLE (0069-0122-02) |
NDC Information of Tessalon
| NDC Code | 0069-0122-02 |
| Proprietary Name | Tessalon |
| Package Description | 500 CAPSULE in 1 BOTTLE (0069-0122-02) |
| Product NDC | 0069-0122 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | benzonatate |
| Dosage Form Name | CAPSULE |
| Route Name | ORAL |
| Start Marketing Date | 19580210 |
| Marketing Category Name | NDA |
| Labeler Name | Pfizer Laboratories |
| Substance Name | BENZONATATE |
| Strength Number | 100 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Decreased Tracheobronchial Stretch Receptor Activity [PE],Non-narcotic Antitussive [EPC] |
